The potential of dual-energy mammography for microcalcification classification was investigated with simulation and phantom studies. Classification of type I/II calcifications was performed using the tissue attenuation ratio as a performance metric. The simulation and phantom studies were carried out using breast phantoms of 50% fibroglandular and 50% adipose tissue composition and thicknessess ranging from 3 to 6 cm. The phantoms included models of microcalcifications ranging in size between 200 and 900 μm. The simulation study was carried out with fixed MGD of 1.5 mGy using various low- and high-kVp spectra, aluminum filtration thicknesses, and exposure distribution ratios to predict an optimized imaging protocol for the phantom study. Attenuation ratio values were calculated for microcalcification signals of different types at two different voltage settings. ROC analysis showed that classification performance as indicated by the area under the ROC curve was always greater than 0.95 for 1.5 mGy deposited mean glandular dose. This study provides encouraging first results in classifying malignant and benign microcalcifications based solely on dual-energy mammography images.
<!-- *** Custom HTML *** --> Purpose: The purpose of this study was to evaluate the potential of a prototype gallium arsenide (GaAs) photon-counting detector (PCD) for imaging of the breast. Approach: First, the contrast-to-noise ratio (CNR) using different aluminum/poly(methyl methacrylate) (PMMA) phantoms of different thicknesses were measured. Second, microcalcification detection accuracy using a receiver operating characteristic study with three observers reading an ensemble of images was measured. Finally, the feasibility of using a GaAs system with two energy bins for contrast-enhanced mammography was investigated. Results: For the first two studies, the GaAs detector was compared with a commercial mammography system. The CNR was estimated by imaging 18-, 36-, and 110-μm-thick aluminum targets placed on top of 6 cm of PMMA plates and was found to be similar or better over a range of exposures. We observed a similar performance of detecting microcalcifications with the GaAs detector over a range of clinically applicable dose levels with a small increase at lower dose levels. The results also showed that contrast-enhanced spectral mammography using a GaAs PCD is feasible and beneficial. Conclusions: Results from this study suggest that performance with this new detector seems either slightly improved or equivalent to a commercial mammography system that used an energy-integrated detector. No attempt at optimizing exposure techniques for the GaAs detector was performed. Further research is needed to determine optimal acquisition parameters for the GaAs detector and to develop more sophisticated material decomposition algorithms that promise to provide improved quantitative estimates of iodine uptake.
19 August 2021 in Biomedical Physics & Engineering Express
Physical breast phantoms can be used to evaluate x-ray imaging systems such as mammography, digital breast tomosynthesis and dedicated breast computed tomography (bCT). These phantoms typically attempt to mimic x-ray attenuation properties of adipose and fibroglandular tissues within the breast. In order to use these phantoms for task-based objective assessment of image quality, relevant diagnostic features should be modeled within the phantom, such as mass lesions and/or microcalcifications. Evaluating imaging system performance in detecting microcalcifications is of particular interest due to its' clinical significance. Many previously-developed phantoms have used materials that model microcalcifications using unrealistic chemical composition, which do not accurately portray their desired x-ray attenuation and scatter properties. We report here on a new method for developing real microcalcification simulants that can be embedded in breast phantoms. This was achieved in several steps, including cross-linking hydroxyapatite and calcium oxalate powders with a binder called polyvinylpyrrolidone (PVP), and mechanical compression. The fabricated microcalcifications were evaluated by measuring their x-ray attenuation and scatter properties using x-ray spectroscopy and x-ray diffraction systems, respectively, and were demonstrated with x-ray mammography and bCT images. Results suggest that using these microcalcification models will make breast phantoms more realistic for use in evaluating task-based detection performance of the abovementioned breast imaging techniques, and bode well for extending their use to spectral imaging and x-ray coherent scatter computed tomography.
Brain aggregates of β amyloid (βA) protein plaques have been widely recognized as associated with many neurodegenerative diseases, and their identification can assist in the early diagnosis of Alzheimer’s disease. We investigate the feasibility of using a spectral x-ray coherent scatter system with a silicon strip photon-counting detector for identifying brain βA protein plaques. This approach is based on differences in the structure of amyloid, white and grey matter in the brain. We simulated an energy- and angular-dispersive X-ray diffraction system with an x-ray pencil beam and Silicon strip sensor, energy-resolving detectors. The polychromatic beam is geometrically focused toward a region of interest in the brain. First, the open-source MC-GPU code for Monte Carlo transport was modified to accommodate the detector model. Second, brain phantoms with and without βA were simulated to assess the method and determine the radiation dose required to obtain acceptable statistical power. For βA targets of 3, 4 and 5 mm sizes in a 15-cm brain model, the required incident exposure was about 0.44 mR from a 60 kVp tungsten spectrum and 3.5 mm of added aluminum filtration. The results suggest that the proposed x-ray coherent scatter technique enables the use of high energy x-ray spectra and therefore has the potential to be used for accurate in vivo detection and quantification of βA in the brain within acceptable radiation dose levels.